Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q04
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,913
Award facts
- Contract value 100% obligated
- $16,913.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for 60 tablets of Otezla 30 mg with a ceiling value of $16,913.35 by the Defense Logistics Agency on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC, designated SPE2DX and valued at $999,999,999.00 through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide.
AmerisourceBergen's role as a pharmaceutical distributor and healthcare solutions provider positions it as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This specific delivery order for Otezla—an immunosuppressant used to treat inflammatory conditions—reflects the company's ongoing support of military medical supply chain requirements under the broader DLA Troop Support Medical framework.
Quick answers
Who was awarded contract SPE2DR26F9Q04?
SPE2DR26F9Q04 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F9Q04 worth?
The government has obligated $16,913 on SPE2DR26F9Q04.
Is contract SPE2DR26F9Q04 an order under another contract?
Yes. SPE2DR26F9Q04 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Q04 competed?
The extent of competition for SPE2DR26F9Q04 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award